# Glioblastoma and Individualized Therapies

> **NCT05356312** · — · AVAILABLE · sponsor: **Zentrum fur Humangenetik Tuebingen**

## Conditions studied

- Glioma, Malignant

## Interventions

- **BIOLOGICAL:** Vaccination

## Key facts

- **NCT ID:** NCT05356312
- **Lead sponsor:** Zentrum fur Humangenetik Tuebingen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05356312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05356312, "Glioblastoma and Individualized Therapies". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05356312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*